These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8339588)

  • 1. Observations on the role of tumor necrosis factor-alpha in a murine model of shock due to Streptococcus pyogenes.
    Wayte J; Silva AT; Krausz T; Cohen J
    Crit Care Med; 1993 Aug; 21(8):1207-12. PubMed ID: 8339588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of anti-TNF-alpha treatment in an antibiotic treated murine model of shock due to Streptococcus pyogenes.
    Martin RA; Silva AT; Cohen J
    FEMS Microbiol Lett; 1993 Jun; 110(2):175-8. PubMed ID: 8349091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial and vascular adrenergic alterations in a rat model of endotoxin shock: reversal by an anti-tumor necrosis factor-alpha monoclonal antibody.
    Boillot A; Massol J; Maupoil V; Grelier R; Bernard B; Capellier G; Berthelot A; Barale F
    Crit Care Med; 1997 Mar; 25(3):504-11. PubMed ID: 9118669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure.
    Stevens DL; Bryant AE; Hackett SP; Chang A; Peer G; Kosanke S; Emerson T; Hinshaw L
    J Infect Dis; 1996 Mar; 173(3):619-26. PubMed ID: 8627025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection.
    Teti G; Mancuso G; Tomasello F
    Infect Immun; 1993 Jan; 61(1):227-35. PubMed ID: 8418044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock.
    Silva AT; Bayston KF; Cohen J
    J Infect Dis; 1990 Aug; 162(2):421-7. PubMed ID: 2373872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphosphoryl lipid A from Rhodopseudomonas sphaeroides induces tolerance to endotoxic shock in the rat.
    Carpati CM; Astiz ME; Saha DC; Rackow EC
    Crit Care Med; 1993 May; 21(5):753-8. PubMed ID: 8482097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The yeast to hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-alpha.
    Matuschak GM; Lechner AJ
    Crit Care Med; 1997 Jan; 25(1):111-20. PubMed ID: 8989186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoethyl-isothiourea, a nitric oxide synthase inhibitor and oxygen radical scavenger, improves survival and counteracts hemodynamic deterioration in a porcine model of streptococcal shock.
    Saetre T; Höiby EA; Aspelin T; Lermark G; Egeland T; Lyberg T
    Crit Care Med; 2000 Aug; 28(8):2697-706. PubMed ID: 10966238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.
    Eskandari MK; Bolgos G; Miller C; Nguyen DT; DeForge LE; Remick DG
    J Immunol; 1992 May; 148(9):2724-30. PubMed ID: 1315357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis.
    Porat R; Paddock HN; Schwaitzberg SD; Connolly RJ; Wilkens T; Dasch JR; Gascon MP; Hutchison JS; Ythier A; Wallach D
    Crit Care Med; 1995 Jun; 23(6):1080-9. PubMed ID: 7774220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.
    Stack AM; Saladino RA; Thompson C; Sattler F; Weiner DL; Parsonnet J; Nariuchi H; Siber GR; Fleisher GR
    Crit Care Med; 1995 Sep; 23(9):1512-8. PubMed ID: 7664553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a human immunoglobulin preparation for intravenous use in a rabbit model of meningococcal endotoxin-induced shock.
    Saladino R; Baldwin G; Alpert G; Parsonnet J; Gillis Z; Thompson C; Siber G; Fleisher G
    Crit Care Med; 1992 Jun; 20(6):816-22. PubMed ID: 1597037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group.
    Fisher CJ; Opal SM; Dhainaut JF; Stephens S; Zimmerman JL; Nightingale P; Harris SJ; Schein RM; Panacek EA; Vincent JL
    Crit Care Med; 1993 Mar; 21(3):318-27. PubMed ID: 8440099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with tumor necrosis factor-alpha attenuates arterial hypotension and mortality induced by endotoxin in pigs.
    Murphey ED; Traber DL
    Crit Care Med; 2000 Jun; 28(6):2015-21. PubMed ID: 10890657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide triggers invasive streptococcal disease in mice through a tumour necrosis factor-alpha-dependent mechanism.
    Diao H; Kohanawa M; Yimin ; Nakajima H; Sato Y; Minagawa T; Nakane A;
    Immunology; 2002 Mar; 105(3):344-9. PubMed ID: 11918696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.
    Abraham E; Wunderink R; Silverman H; Perl TM; Nasraway S; Levy H; Bone R; Wenzel RP; Balk R; Allred R
    JAMA; 1995 Mar 22-29; 273(12):934-41. PubMed ID: 7884952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group.
    Dhainaut JF; Vincent JL; Richard C; Lejeune P; Martin C; Fierobe L; Stephens S; Ney UM; Sopwith M
    Crit Care Med; 1995 Sep; 23(9):1461-9. PubMed ID: 7664546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.
    Cohen J; Carlet J
    Crit Care Med; 1996 Sep; 24(9):1431-40. PubMed ID: 8797612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody.
    Hinshaw LB; Emerson TE; Taylor FB; Chang AC; Duerr M; Peer GT; Flournoy DJ; White GL; Kosanke SD; Murray CK
    J Trauma; 1992 Oct; 33(4):568-73. PubMed ID: 1433404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.